Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 7/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sumiki'S Acid SCHEMBL29706392 | 1.00 | TDP1 (1.00) | TDP1ALDH1A1TSHRPOLBL3MBTL1 | |
| SCHEMBL901472 | 0.84 | TDP1 (0.72) | TDP1ALDH1A1POLBL3MBTL1MAPT | |
| Sumiki'S Acid SCHEMBL28619852 | 0.83 | TDP1 (0.69) | TDP1ALDH1A1TSHRPOLBL3MBTL1 | |
| SCHEMBL27313148 | 0.83 | TDP1 (0.70) | TDP1ALDH1A1POLBL3MBTL1MAPT | |
| SCHEMBL8610246 | 0.82 | TDP1 (0.69) | TDP1ALDH1A1POLBL3MBTL1MAPT | |
| SCHEMBL6447185 | 0.82 | TDP1 (0.69) | TDP1ALDH1A1TSHRPOLBL3MBTL1 | |
| Aes-103 SCHEMBL28643076 | 0.82 | ALDH1A1 (0.73) | TDP1ALDH1A1TSHRPOLBL3MBTL1 | |
| SCHEMBL4442918 | 0.80 | TDP1 (0.67) | TDP1ALDH1A1POLBL3MBTL1MAPT | |
| SCHEMBL3562210 | 0.80 | TDP1 (0.67) | TDP1ALDH1A1POLBL3MBTL1MAPT | |
| SCHEMBL183409 | 0.80 | TDP1 (0.67) | TDP1ALDH1A1POLBL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1715 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778580-B1 | SYNTHESIS OF FURANS FROM SUGARS VIA KETO INTERMEDIATES | BP CORP NORTH AMERICA INC (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4649073-A1 | METHOD OF OXIDIZING ALDEHYDES | Resource Chemical Corporation (US) | 2025-11-19 | — | — | EP | claimed |
| US-20250320534-A1 | COMPOSITIONS AND METHODS FOR PRODUCING DIHYDROFURANS FROM KETO-SUGARS | ARZEDA CORP (US) | 2025-10-16 | — | — | US | claimed |
| US-20250197367-A1 | PROCESS FOR THE OXIDATION OF HYDROXYMETHYLFURFURAL | Südzucker AG (DE) | 2025-06-19 | — | — | US | claimed |
| CN-116637634-B | Preparation and application of furanmethanol compound hydrogenolysis catalyst | 南昌大学 | 2025-06-13 | — | — | CN | claimed |
| CN-120058655-A | Preparation method of 5-hydroxymethyl furoic acid | 莆田达凯新材料有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120041518-A | Method for synthesizing furan acid compound by catalyzing 5-hydroxymethylfurfural through chemical enzyme cascade | 南京工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119985789-A | Method for simultaneously measuring 5-hydroxymethylfurfural and oxidation products thereof | 中国科学院宁波材料技术与工程研究所 | 2025-05-13 | — | — | CN | claimed |
| CN-119915931-A | HPLC (high Performance liquid chromatography) characteristic spectrum construction method for pollen typhae medicinal materials, fried pollen typhae decoction pieces, standard decoction and prescription granule thereof | 四川厚宇中药有限公司 | 2025-05-02 | — | — | CN | claimed |
| US-20250136566-A1 | FURAN DICARBOXYLIC ACID COMPOUND, METHOD FOR PREPARING FURAN DICARBOXYLIC ACID COMPOUND, POLYESTER, AND MEHTOD FOR PREPARING POLYESTER | KOLON INDUSTRIES, INC. (KR) | 2025-05-01 | — | — | US | claimed |
| EP-1834951-A1 | Method for the synthesis of organic acid esters of 5-hydroxymethylfurfural and their use | Avantium International B.V. (NL) | 2007-09-19 | — | — | EP | claimed |
| US-20070185096-A1 | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein | NOVARTIS PHARMACEUTICALS CORPORATION (US) | 2007-08-09 | — | — | US | claimed |
| CN-1933841-A | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein | ARROW THERAPEUTICS LTD (GB) | 2007-03-21 | — | — | CN | claimed |
| CN-1929848-A | Benzodiazepines for treating or preventing or preventing RSV infection | ARROW THERAPEUTICS LTD (GB) | 2007-03-14 | — | — | CN | claimed |
| EP-1740185-A1 | BENZODIAZEPINES FOR TREATING OR PREVENTING RSV INFECTION | Arrow Therapeutics Limited (GB) | 2007-01-10 | — | — | EP | claimed |
| EP-1727551-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A BENZODIAZEPINE DERIVATIVE AND A INHIBITOR OF THE RSV FUSION PROTEIN | Arrow Therapeutics Limited (GB) | 2006-12-06 | — | — | EP | claimed |
| WO-2005089770-A1 | BENZODIAZEPINES FOR TREATING OR PREVENTING OR PREVENTING RSV INFECTION | ARROW THERAPEUTICS LIMITED (GB) | 2005-09-29 | — | — | WO | claimed |
| WO-2005090319-A1 | PROCESS FOR PREPARING BENZODIAZEPINES | ARROW THERAPEUTICS LIMITED (GB) | 2005-09-29 | — | — | WO | claimed |
| WO-2005089771-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A BENZODIAZEPINE DERIVATIVE AND A INHIBITOR OF THE RSV FUSION PROTEIN | ARROW THERAPEUTICS LIMITED (GB) | 2005-09-29 | — | — | WO | claimed |
| US-5686311-A | ANALYZING FLUID SAMPLE | THE CHILDREN'S MERCY HOSPITAL (US) | 1997-11-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185096-A1 | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein | GABRP, TSPO, GABRA1 | TDP1 3562/4885ALDH1A1 3840/4885TSHR 2549/4885 |
| US-20250320534-A1 | COMPOSITIONS AND METHODS FOR PRODUCING DIHYDROFURANS FROM KETO-SUGARS | DERA, KHK, HK2 | TDP1 1840/4885ALDH1A1 1298/4885TSHR 4763/4885 |
| US-20250136566-A1 | FURAN DICARBOXYLIC ACID COMPOUND, METHOD FOR PREPARING FURAN DICARBOXYLIC ACID COMPOUND, POLYESTER, AND MEHTOD FOR PREPARING POLYESTER | HADH, DHODH, HAAO | TDP1 3910/4885ALDH1A1 956/4885TSHR 4028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.